Literature DB >> 17889965

Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock.

Ryan Dackor1, Kathleen Caron.   

Abstract

Adrenomedullin (AM) is a highly conserved peptide that can act as a potent vasodilator, anti-microbial factor and anti-inflammatory factor. Several studies have implicated diverse roles for AM in regulating the inflammatory and hemodynamic responses to septic shock. Moreover, during sepsis the receptors that mediate AM signaling [calcitonin receptor-like receptor (calcrl) and receptor activity modifying proteins (RAMP) 2 and 3] undergo dynamic and robust changes in their expression. Although numerous studies have used animal models to study the role of administered or increased AM in septic animals, genetic studies to determine the consequences of reduced AM during septic shock have not yet been performed. Here, we used a murine model of lipopolysaccharide (LPS)-induced septic shock to assess the inflammatory response in mice heterozygous for the AM gene. Following LPS challenge, AM(+/-) mice had higher expression of TNF-alpha and IL-1beta than LPS-treated wild-type (WT) controls. Consequently, serum TNF-alpha was also significantly elevated in LPS-treated AM(+/-) mice compared to WT LPS-treated mice. We also observed higher serum levels of liver enzymes, suggesting more advanced end-organ damage in mice with genetically reduced AM. Finally, we found that RAMP2 and calcrl expression levels were markedly reduced in LPS-treated mice, whereas RAMP3 expression was significantly elevated. Importantly, these changes in receptor gene expression were conserved in AM(+/-) mice, demonstrating that AM peptide itself does not impact directly on the expression of the genes encoding its receptors. We, therefore, conclude that during septic shock the dynamic modulation of AM and its receptors primarily functions to dampen the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889965      PMCID: PMC2121581          DOI: 10.1016/j.peptides.2007.08.012

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  37 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis.

Authors:  Y Ono; I Okano; M Kojima; K Okada; K Kangawa
Journal:  Biochem Biophys Res Commun       Date:  2000-04-29       Impact factor: 3.575

3.  Saturation of adrenomedullin receptors plays an important role in reducing pulmonary clearance of adrenomedullin during the late stage of sepsis.

Authors:  David A Ornan; Irshad H Chaudry; Ping Wang
Journal:  Biochim Biophys Acta       Date:  2002-04-24

4.  Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature.

Authors:  T Shindo; H Kurihara; K Maemura; Y Kurihara; T Kuwaki; T Izumida; N Minamino; K H Ju; H Morita; Y Oh-hashi; M Kumada; K Kangawa; R Nagai; Y Yazaki
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

5.  Adrenomedullin suppresses interleukin-1beta-induced tumor necrosis factor-alpha production in Swiss 3T3 cells.

Authors:  Y Isumi; A Kubo; T Katafuchi; K Kangawa; N Minamino
Journal:  FEBS Lett       Date:  1999-12-10       Impact factor: 4.124

6.  Cardioprotective effect of oleanolic acid on isoproterenol-induced myocardial ischemia in rats.

Authors:  S Senthil; M Sridevi; K V Pugalendi
Journal:  Toxicol Pathol       Date:  2007-04       Impact factor: 1.902

7.  The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis.

Authors:  Takashi Kagari; Hiromi Doi; Takaichi Shimozato
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  Adrenomedullin reduces endothelial hyperpermeability.

Authors:  Stefan Hippenstiel; Martin Witzenrath; Bernd Schmeck; Andreas Hocke; Mathias Krisp; Matthias Krüll; Joachim Seybold; Werner Seeger; Wolfgang Rascher; Hartwig Schütte; Norbert Suttorp
Journal:  Circ Res       Date:  2002-10-04       Impact factor: 17.367

9.  Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis.

Authors:  Mian Zhou; Zheng F Ba; Irshad H Chaudry; Ping Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-09       Impact factor: 3.619

10.  Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene.

Authors:  K M Caron; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

View more
  12 in total

1.  Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner.

Authors:  Cordelia J Barrick; Patricia M Lenhart; Ryan T Dackor; Elizabeth Nagle; Kathleen M Caron
Journal:  J Mol Cell Cardiol       Date:  2011-11-04       Impact factor: 5.000

2.  Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis.

Authors:  Claudia Sardi; Laura Zambusi; Annamaria Finardi; Francesca Ruffini; Adviye A Tolun; Ian M Dickerson; Marco Righi; Daniele Zacchetti; Fabio Grohovaz; Luciano Provini; Roberto Furlan; Stefano Morara
Journal:  J Neuroimmunol       Date:  2014-03-19       Impact factor: 3.478

3.  Human vasoactive hormone adrenomedullin and its binding protein rescue experimental animals from shock.

Authors:  Rongqian Wu; Weifeng Dong; Xiaoling Qiang; Youxin Ji; Tianpen Cui; Juntao Yang; Mian Zhou; Steven Blau; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Peptides       Date:  2008-03-08       Impact factor: 3.750

4.  Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction.

Authors:  Svenja Hinrichs; Katharina Scherschel; Saskia Krüger; Johannes Tobias Neumann; Michael Schwarzl; Isabell Yan; Svenja Warnke; Francisco M Ojeda; Tanja Zeller; Mahir Karakas; Till Keller; Christian Meyer; Stefan Blankenberg; Dirk Westermann; Diana Lindner
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-30       Impact factor: 11.205

5.  Reversing established sepsis in rats with human vasoactive hormone adrenomedullin and its binding protein.

Authors:  Rongqian Wu; Shinya Higuchi; Weifeng Dong; Youxin Ji; Mian Zhou; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Mol Med       Date:  2008-10-10       Impact factor: 6.354

6.  Inhibition of lipopolysaccharide-induced microglia activation by calcitonin gene related peptide and adrenomedullin.

Authors:  Alessandra Consonni; Stefano Morara; Franca Codazzi; Fabio Grohovaz; Daniele Zacchetti
Journal:  Mol Cell Neurosci       Date:  2011-07-22       Impact factor: 4.314

7.  Adrenomedullin Deficiency Potentiates Lipopolysaccharide-Induced Experimental Bronchopulmonary Dysplasia in Neonatal Mice.

Authors:  Amrit K Shrestha; Renuka T Menon; Chandrasekhar Yallampalli; Roberto Barrios; Binoy Shivanna
Journal:  Am J Pathol       Date:  2021-09-09       Impact factor: 4.307

Review 8.  Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Authors:  Ramiro Vázquez; Maria E Riveiro; Caroline Berenguer-Daizé; Anthony O'Kane; Julie Gormley; Olivier Touzelet; Keyvan Rezai; Mohamed Bekradda; L'Houcine Ouafik
Journal:  Front Oncol       Date:  2021-01-06       Impact factor: 6.244

9.  Regional haemodynamic responses to adenosine receptor activation vary across time following lipopolysaccharide treatment in conscious rats.

Authors:  L Jolly; J E March; P A Kemp; T Bennett; S M Gardiner
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

Review 10.  Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives.

Authors:  Holger C Müller-Redetzky; Norbert Suttorp; Martin Witzenrath
Journal:  Cell Tissue Res       Date:  2014-03-06       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.